{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:05:08Z","timestamp":1792263908711,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jhep.2025.06.019","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:09:02Z","timestamp":1752581342000},"page":"1320-1327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3974-2784","authenticated-orcid":false,"given":"Thierry","family":"Th\u00e9venot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Elkrief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Bardou-Jacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Oberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Pitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-1580","authenticated-orcid":false,"given":"Fanny","family":"Leboss\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5293-007X","authenticated-orcid":false,"given":"Alexandre","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Nahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5254-2464","authenticated-orcid":false,"given":"Isabelle","family":"Ollivier-Hourmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Anty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Francoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Riachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7260-2535","authenticated-orcid":false,"given":"Alexandre","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Cervoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Tio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audace","family":"Cur\u00e9-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9113-1381","authenticated-orcid":false,"given":"Ruben","family":"Ladeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6938-6771","authenticated-orcid":false,"given":"Anne-Laure","family":"Clairet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-7238","authenticated-orcid":false,"given":"Didier","family":"Hocquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2022-690X","authenticated-orcid":false,"given":"Vincent","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9648-813X","authenticated-orcid":false,"given":"Delphine","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3801-5297","authenticated-orcid":false,"given":"Maxime","family":"Desmarets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.06.019_bib1","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMra2021808","article-title":"The evolving challenge of infections in cirrhosis","volume":"384","author":"Bajaj","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2025.06.019_bib2","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of long-term norfloxacin therapy in patients with advanced cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.06.019_bib3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.06.019_bib4","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.06.019_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001251","article-title":"Clinical outcomes and care for spontaneous bacterial peritonitis: a national cohort study","author":"Serper","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/hep.28330","article-title":"Antibiotic prophylaxis in cirrhosis: good and bad","volume":"63","author":"Fern\u00e1ndez","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.06.019_bib8","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites and hepatorenal syndrome","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.06.019_bib11","first-page":"CD013125","article-title":"Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis","volume":"1","author":"Komolafe","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2025.06.019_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"70","author":"Aithal","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.06.019_bib13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.06.019_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127448","article-title":"The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey","volume":"10","author":"Merli","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.jhep.2025.06.019_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10096-023-04572-2","article-title":"Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections","volume":"42","author":"Marciano","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhep.2025.06.019_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2025.06.019_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00039-23","article-title":"The potential for development of clinically relevant microbial resistance to rifaximin-\u03b1: a narrative review","volume":"36","author":"Dupont","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhep.2025.06.019_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","article-title":"Rifaximin-alpha reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial","volume":"76","author":"Patel","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.06.019_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2025.06.019_bib20","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1053\/j.gastro.2016.02.074","article-title":"Treatment of severe alcoholic hepatitis","volume":"150","author":"Thursz","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.06.019_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2468-1253(23)00010-9","article-title":"Rifaximin-\u03b1 for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Israelsen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.06.019_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2307\/2531910","article-title":"Sample sizes based on the log-rank statistic in complex clinical trials","volume":"44","author":"Lakatos","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jhep.2025.06.019_bib23","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"Bataller","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2025.06.019_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2023.03.042","article-title":"Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatments","volume":"79","author":"Eriksen","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.06.019_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/liv.12093","article-title":"A national French survey on the use of antibiotic prophylaxis in cirrhotic patients","volume":"33","author":"Thevenot","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.06.019_bib26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1186\/s13063-022-06727-6","article-title":"ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trial","volume":"23","author":"Crocombe","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.jhep.2025.06.019_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12072-019-10004-1","article-title":"Antimicrobial resistance in chronic liver disease","volume":"14","author":"Patel","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2025.06.019_bib28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.14309\/ajg.0000000000000280","article-title":"Nosocomial infections are frequent and negatively impact outcomes in hospitalized patients with cirrhosis","volume":"114","author":"Bajaj","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.06.019_bib29","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1097\/HEP.0000000000000184","article-title":"Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration","volume":"77","author":"Badal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib30","article-title":"Fluoroquinolones: clearer evidence and guidance on safety are needed","volume":"385","author":"Hamilton","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2025.06.019_bib31","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acuteon- chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.06.019_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.06.019_bib33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0016-5085(86)90185-X","article-title":"Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis","volume":"91","author":"Runyon","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.06.019_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.1840080107","article-title":"Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors","volume":"8","author":"Tit\u00f3","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.1840160318","article-title":"Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration","volume":"16","author":"Llach","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0016-5085(93)90284-J","article-title":"Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites","volume":"104","author":"Andreu","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.06.019_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2015.03.040","article-title":"Low ascitic fluid protein does not indicate an increased risk for spontaneous bacterial peritonitis in current cohorts","volume":"63","author":"Bruns","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.06.019_bib38","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jhep.2014.11.036","article-title":"Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study","volume":"62","author":"Terg","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.06.019_bib39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/00365521.2017.1411973","article-title":"Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis","volume":"53","author":"Mo","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.06.019_bib40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D\u2019Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.06.019_bib42","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cgh.2013.12.021","article-title":"Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy","volume":"12","author":"Mullen","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.06.019_bib43","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/hep.31708","article-title":"The use of rifaximin in patients with cirrhosis","volume":"74","author":"Caraceni","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.06.019_bib44","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cgh.2022.05.042","article-title":"Dosing of rifaximin soluble solid dispersion tablets in adults with cirrhosis: 2 randomized, placebo-controlled trials","volume":"21","author":"Bajaj","year":"2023","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825023189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825023189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:57:16Z","timestamp":1777510636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825023189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0168827825023189"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.06.019","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}